Default: Bioorganic and Medicinal Chemistry Letters

ISSN: 0960-894X

Journal Home

Journal Guideline

Bioorganic and Medicinal Chemistry Letters Q1 Unclaimed

Elsevier Ltd. United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Bioorganic and Medicinal Chemistry Letters is a journal indexed in SJR in Molecular Biology and Biochemistry with an H index of 141. It has an SJR impact factor of 0,64 and it has a best quartile of Q1. It is published in English.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Metrics

Bioorganic and Medicinal Chemistry Letters

0,64

SJR Impact factor

141

H Index

609

Total Docs (Last Year)

2860

Total Docs (3 years)

19295

Total Refs

7487

Total Cites (3 years)

2828

Citable Docs (3 years)

2,64

Cites/Doc (2 years)

31,68

Ref/Doc


Best articles

2-(Anilinomethyl)imidazolines as a1-adrenoceptor agonists: the identification of a1A subtype selective 2'-carboxylic acid esters and amides

View more

2-Aryl indole NK1 antagonists: optimisation of the amide substituent

View more

2-Nitro analogues of adenosine and 1-deazaadenosine: synthesis and binding studies at the adenosine A1, A2A and A3 receptor subtypes

View more

3-Aryl-4-aryloyl-1-(1H-imidazol-5-yl)methylpyrrole, a novel class of farnesyltransferase inhibitors

View more

5-HETE congeners as modulators of cell proliferation

View more

6-bicyclopiperazinyl-1-arylsulfonylindoles and 6-bicyclopiperidinyl-1-arylsulfonylindoles derivatives as novel, potent, and selective 5-HT6 receptor antagonists

View more

7-Nitrobenzofurazan (NBD) derivatives of 5'-N-ethylcarboxamidoadenosine (NECA) as new fluorescent probes for human A3 adenosine receptors

View more

A case study of combinatorial libraries: Endothelin receptor antagonist hexapeptides

View more

A convenient synthesis of novel bifunctional prochelators for coupling to bioactive peptides for radiometal labelling

View more

A new deprotection strategy for automated oligonucleotide synthesis using a novel silyl-linked solid support

View more

A novel series of highly potent 5-lipoxygenase inhibitors; 2-aryldienylbenzoxazoles

View more

A QSAR study investigating the effect of l-alanine ester variation on the anti-HIV activity of some phosphoramidate derivatives of d4T

View more
SHOW MORE ARTICLES

A Unique Ring-Expanded Acyclic Nucleoside Analogue that Inhibits Both Adenosine Deaminase (ADA) and Guanine Deaminase (GDA; Guanase): Synthesis and Enzyme Inhibition Studies of 4,6-Diamino-8H-1-hydroxyethoxymethyl-8-iminoimidazo[4,5-e][1,3]diazepine

View more

Amino acid phosphoramidate nucleosides: potential ADEPT/GDEPT substrates

View more

Amino azoles and azolo-azines as potential hepatoprotectants: Part III

View more

Anionic Cyclophanes as Potential Reversal Agents of Muscle Relaxants by Chemical Chelation

View more

Assamicin I and II, Novel Triterpenoid Saponins with Insulin-Like Activity from Aesculus assamica Griff.

View more

Biologically active oligodeoxyribonucleotides. Part 12:1 N2-Methylation of 2'-deoxyguanosines enhances stability of parallel G-quadruplex and anti-HIV-1 activity

View more

Cellular solid-phase binding assay and mass spectrometry for screening of a4beta7 integrin antagonists

View more

Computational binding studies of human pp60c-src SH2 domain with a series of nonpeptide, phosphophenyl-containing ligands

View more

Conformationally-restricted ligands for the histamine H 1 receptor

View more

Copper-Promoted overall transformation of 4- tert -butylphenol to its para -hydroxyquinonic derivative, 2-hydroxy-5- tert -butyl-1,4-benzoquinone. Biomimetic studies on the generation of topaquinone in copper amine oxidases

View more

Corrigendum to "Amino acid derived sulfonamide hydroxamates as inhibitors of procollagen C-proteinase: solid-phase synthesis of ornithine analogues"[Bioorg. Med. Chem. Lett. 11 (2001) 2085]†

View more

Corrigendum to "First pharmacophoric hypothesis for 5-HT7 antagonism"

View more

Comments

No comments ... Be the first to comment!